Artículos del autor

solaci

Is V-in-V the Treatment of Choice in Cases of Failed Biological Prosthesis?

Courtesy of Dr. Carlos Fava. The treatment of choice for failed biological aortic prostheses has always been redo surgery...

Always in Favor of Primary Angioplasty, Even in the Pandemic Era

Compared with fibrinolytic therapy, reperfusion through primary angioplasty is more reliable and durable, and has less complications....

In Favor of the Use of Thrombolytics in Pandemic Times

The Covid-19 pandemic has dramatically altered reperfusion therapy access in patients undergoing ST elevation MI. In these...

Newsletter #276: Stay Updated in Interventional Cardiology

Read the #276 SOLACI Newsletter with all the news about Interventional Cardiology and events to add to...

Management of Infarction During the COVID-19 Pandemic

Patients with cardiovascular disease infected with COVID-19 are at a particular risk for morbidity and mortality. In...

Thrombosis and Thromboembolism Associated with COVID-19

Coronavirus disease 2019 (COVID-19) is a viral respiratory illness that can cause a severe acute respiratory syndrome...

SOLACI PERIPHERAL | A New SOLACI Department

We are pleased to announce the creation of SOLACI’s new Department of Peripheral Endovascular Interventions. Its name is...

How is the Pandemic Affecting MI? The Chinese Experience

ST elevation acute myocardial infarction has high mortality and morbidity rates. It is normally treated with primary...